HIV-1 subtype C Gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 4, 2007, Pages 389-400

  Tsegaye, Aster ^a   Ran, Leonie ^b,f   Wolday, Dawit ^a   Petros, Beyene ^c   Dorigo, Wendelien ^a   Piriou, Erwan ^b   Messele, Tsehaynesh ^a   Sanders, Eduard ^a   Tilahun, Tesfaye ^a   Eshetu, Deresse ^a   Schuitemaker, Hanneke ^b   Coutinho, Roel A ^d   Miedema, Frank ^b,e,f   Borghans, José ^b,f   Baarle, Debbie Van ^b,f  

^a ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d Municipal Health Office   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Africa; Cytotoxic T lymphocyte response; Enzyme linked immunospot assay; Ethiopia; HIV subtype C; Human leukocyte antigen class I

Indexed keywords

GAG PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; ISOLEUCYLLYSYLHISTIDYLLEUCYLVALYLTRYPTOPHYLALANYLSERYLARGINYL GLUTAMYLLEUCYLGLUTAMYLARGINYLPHENYLALANYLALANYLLEUCYLASPARAGINYLPROLYL GLYCYLLEUCINE; ISOLEUCYLTYROSYLLYSYLARGINYLTRYPTOPHYLISOLEUCYLISOLEUCYLLEUCYLGLYCYL LEUCYLASPARAGINYLLYSYLISOLEUCYLVALYLARGINYLMETHIONYLTYROSYLSERYLPROLYLVALINE; LYSYLTHREONYLISOLEUCYLLEUCYLLYSYLALANYLLEUCYLGLYCYLPROLYLGLYCYL ALANYLTHREONYLLEUCYLGLUTAMYLGLUTAMYLMETHIONYLMETHIONYLTHREONYLALANYLCYSTEINE; METHIONYLPHENYLALANYLTHREONYLALANYLLEUCYLSERYLGLUTAMYLGLYCYLALANYL THREONYLPROLYLGLUTAMINYLASPARTYLLEUCYLASPARAGINYLTHREONYLMETHIONYLLEUCYL ASPARAGINYLTHREONINE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AFRICA; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; ETHIOPIA; ETHNIC DIFFERENCE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; GENE PRODUCTS, GAG; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 34447333149     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318059beaa     Document Type: Article

References (63)

1. Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425-1431.
2. Tsega E, Mengesha B, Nordenfelt E, et al. Serological survey of human immunodeficiency virus infection in Ethiopia. Ethiop Med J. 1988;26:179-184.
3. Abebe A, Lukashov VV, Pollakis G, et al. Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification. AIDS. 2001;15:1555-1561.
4. Abebe A, Lukashov VV, Rinke deWit TF, et al. Timing of the introduction into Ethiopia of subcluster C' of HIV type 1 subtype C. AIDS Res Hum Retroviruses. 2001;17:657-661.
5. Fontanet AL, Messele T, Dejene A, et al. Age-and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. AIDS. 1998;12:315-322.
6. Tsegaye A, Rinke de Wit TF, Mekonnen Y, et al. Decline in prevalence of HIV-1 infection and syphilis among young women attending antenatal care clinics in Addis Ababa, Ethiopia: results from sentinel surveillance, 1995-2001. J Acquir Immune Defic Syndr. 2002;30:359-362.
7. Aklilu M, Messele T, Tsegaye A, et al. Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS. 2001;15:87-96.
8. Hussein M, Abebe A, Pollakis G, et al. HIV-1 subtype C in commercial sex workers in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2000;23:120-127.
9. Abebe A, Kuiken CL, Goudsmit J, et al. HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res Hum Retroviruses. 1997;13:1071-1075.
10. Ayehunie S, Johansson B, Salminen M, et al. HIV-1 in Ethiopia: phylogenetic divergence from other HIV-1 strains. Virus Genes. 1991;5:359-366.
11. Sherefa K, Sallberg M, Sonnerborg A. Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993. AIDS Res Hum Retroviruses. 1994;10:1551-1556.
12. Abebe A, Pollakis G, Fontanet AL, et al. Identification of a genetic subcluster of HIV type 1 subtype C (C′) widespread in Ethiopia. AIDS Res Hum Retroviruses. 2000;16:1909-1914.
13. Rinke de Wit TF, Tsegaye A, Wolday D, et al. Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr. 2002;30:463-470.
14. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004;432:769-775.
15. Kassu A, Tsegaye A, Petros B, et al. Distribution of lymphocyte subsets in healthy human immunodeficiency virus-negative adult Ethiopians from two geographic locales. Clin Diagn Lab Immunol. 2001;8:1171-1176.
16. Tsegaye A, Wolday D, Otto S, et al. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol. 2003;109:338-346.
17. Tsegaye A, Messele T, Tilahun T, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol. 1999;6:410-414.
18. Mekonnen Y, Geskus RB, Hendriks JC, et al. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers. J Infect Dis. 2005;192:739-748.
19. McMichael A, Hanke T. The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? Nat Rev Immunol. 2002;2:283-291.
20. Kaul R, Dong T, Plummer FA, et al. CD8(+) lymphocytes respond to different HIVepitopes in seronegative and infected subjects. J Clin Invest. 2001;107:1303-1310.
21. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med. 1995;1:59-64.
22. Rowland-Jones SL, Dong T, Fowke KR, et al. Cytotoxic T cell responses to multiple conserved HIVepitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest. 1998;102:1758-1765.
23. Zhang H, Dornadula G, Alur P, et al. Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription. Proc Natl Acad Sci USA. 1996;93:12519-12524.
24. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;189:991-998.
25. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857-860.
26. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68:6103-6110.
27. Gloster SE, Newton P, Cornforth D, et al. Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection. AIDS. 2004;18:749-755.
28. Goulder PJ. Rapid characterization of HIV clade C-specific cytotoxic T lymphocyte responses in infected African children and adults. Ann NY Acad Sci. 2000;918:330-345.
29. Koup RA, Safrit JT, Cao Y, et al. Temporal associations of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
30. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998;279:2103-2106.
31. Thakar MR, Patke D, Lakhashe SK, et al. Consistent subtype-specific anti-HIV type 1 T lymphocyte responses in Indian subjects recently infected with HIV type 1. AIDS Res Hum Retroviruses. 2002;18:1389-1393.
32. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1 specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 1997;3:205-211.
33. Goulder PJR, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997;3:212-217.
34. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. 2002;415:335-339.
35. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188:2199-2204.
36. Osmanov S, Pattou C, Walker N, et al. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr. 2002;29:184-190.
37. Masemola A, Mashishi T, Khoury G, et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol. 2004;78:3233-3243.
38. Day CL, Kiepiela P, Leslie AJ, et al. Proliferative capacity of epitopespecific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J Virol. 2007;81:434-438.
39. Coplan PM, Gupta SB, Dubey SA, et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis. 2005;191:1427-1434.
40. Gupta SB, Mast CT, Wolfe ND, et al. Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. J Acquir Immune Defic Syndr. 2006;42:135-139.
41. Goulder PJ, Brander C, Annamalai K, et al. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol. 2000;74:5679-5690.
42. Novitsky V, Rybak N, McLane MF, et al. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific Elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol. 2001;75:9210-9228.
43. Honeyborne I, Prendergast A, Pereyra F, et al. Control of HIV-1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T cell epitopes. J Virol. 2007;81:3667-3672.
44. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:46-53.
45. Ferrari G, Currier JR, Harris ME, et al. HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians. Hum Immunol. 2004;65:648-659.
46. Mekonnen Y, Sanders E, Aklilu M, et al. Evidence of changes in sexual behaviours among male factory workers in Ethiopia. AIDS. 2003;17:223-231.
47. Sahlu T, Kassa E, Agonafer T, et al. Sexual behaviours, perception of risk of HIV infection, and factors associated with attending HIV post-test counselling in Ethiopia. AIDS. 1999;13:1263-1272.
48. Mashishi T, Gray CM. The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes. Clin Chem Lab Med. 2002;40:903-910.
49. Novitsky V, Gilbert P, Peter T, et al. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol. 2003;77:882-890.
50. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood. 2003;101:2711-2720.
51. Jansen CA, De C I, Hooibrink B, et al. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analysed in a prospective cohort study. Blood. 2006;107:1427-1433.
52. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001;344:1668-1675.
53. Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphisms. Immunogenetics. 1999;50:201-212.
54. Frahm N, Korber BT, Adams CM, et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immuno-deficiency virus across multiple ethnicities. J Virol. 2004;78:2187-2200.
55. Altfeld M, Addo MM, Shankarappa R, et al. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol. 2003;77:7330-7340.
56. Salminen MO, Johansson B, Sonnerborg A, et al. Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses. 1996;12:1329-1339.
57. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol. 2003;77:2081-2092.
58. Tsegaye A, Wolday D, Otto S, et al. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol. 2003;109:338-346.
59. Kassu A, Tsegaye A, Wolday D, et al. Role of incidental and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clin Exp Immunol. 2003;132:113-119.
60. van Baarle D, Tsegaye A, Miedema F, et al. Significance of senescence for virus-specific memory T cell responses: rapid ageing during chronic stimulation of the immune system. Immunol Lett. 2005;97:19-29.
61. Edwards BH, Bansal A, Sabbaj S, et al. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol. 2002;76:2298-2305.
62. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001;75:11983-11991.
63. Goulder PJR, Brander C, Tang Y, et al. Evolution and transmission of stable CTL escape mutants in HIV infection. Nature. 2001;412:334-338.